Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 1,727 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AIMS Clear all

Conditions: Neoplasms, Breast Neoplasms
Interventions: Xentuzumab, Abemaciclib, Letrozole, Anastrozole, Fulvestrant; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 6
States / cities: Santa Monica, California • New Haven, Connecticut • Miami, Florida + 3 more

Conditions: Bladder Cancer
Interventions: ERAS Protocol, Standard of Care; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: ALL, Childhood, Behavior, Health
Interventions: NOURISH-ALL; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 2 Years to 12 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Kansas City, Kansas • Kansas City, Missouri

Conditions: Chronic Kidney Diseases
Interventions: Pioglitazone, Placebo; Drug · Other
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 35 Years to 70 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Arlington, Texas • Dallas, Texas

Conditions: Mental Health Issue, Children, Adult
Interventions: After-Action Review; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Chronic Kidney Diseases
Interventions: CC Program; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Childhood Obesity
Interventions: Healthy Eating and Physical Activity; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 6 Years to 14 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Spina Bifida, Myelomeningocele
Interventions: Phase One: Exploration, Phase Two: Creation, Phase Three: Reflection, Aim 3; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 8 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Bibliotherapy
Interventions: Doing What Matters in Times of Stress: An Illustrated Guide; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Pediatric Cancer
Interventions: eSCCIP/eSCCIP-SP, Coping Space; Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: Not listed
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Los Angeles, California • Wilmington, Delaware • Houston, Texas

Conditions: Depression, Anxiety, Metastatic Cancer
Interventions: Multi-Modal Palliative Care Intervention, Usual Care Control Condition; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Pressure Ulcer
Interventions: 2 hour repositioning, 3 hour repositioning, 4 hour repositioning; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 2,113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Wallingford, Connecticut

Conditions: Postural Tachycardia Syndrome (POTS)
Interventions: Measurement of Splanchnic venous capacitance(SVC)done at Baseline and after 90 min of 75 g glucose in Healthy Controls POTS patients, Measurement of Splanchnic venous capacitance(SVC)done at Baseline and after 90 min of 75 g glucose in Healthy Controls, Compare change is SVC and SMA flow due to GIP antagonist GIP(3-30)NH2, Compare change is SVC and SMA flow due to saline; Diagnostic Test · Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Medication Errors and Other Product Use Errors and Issues
Interventions: Med@HOME Mobile App; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: Not listed
Enrollment: 336 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Dementia, Postoperative Delirium (POD), Postoperative Neurocognitive Disorder, Major Adverse Cardiac and Cerebrovascular Events, Perioperative Complications, Postoperative Cognitive Decline
Interventions: Personalized CPC Prehabilitation, Cognitive Training, Meditation, Daily Exercise, Enhanced Social Support, Proactive Bundle Interventions, Pre-operative Standard of Care, Intra-operative Standard of Care; Other · Behavioral · Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: Pittsburgh, Pennsylvania

Conditions: Cancer
Interventions: Patient Navigator (PN), Baseline Questionnaire, Follow-up Questionnaire, Patient Navigator Satisfaction Survey; Behavioral · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years to 39 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Cancer Surveillance
Interventions: Patient SOGI Self-Report, SOGI Resource for Clinical Care Education (SORCE), Cancer Center Care Environment; Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: HIV/AIDS, Substance Use Disorders
Interventions: DOORS-CHW Intervention; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Relapsed/Refractory Multiple Myeloma
Interventions: Dose Escalation, MEDI2228, ADC (antibody drug conjugate), Dose Expansion, MEDI2228, ADC (antibody drug conjugate); Biological
Lead sponsor: MedImmune LLC; Industry
Eligibility: 18 Years to 101 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 8
States / cities: Phoenix, Arizona • Jacksonville, Florida • Boston, Massachusetts + 4 more

Conditions: Burn Wound
Interventions: Indocyanine green (ICG), Clinical Fluorescence Imaging Device; Drug · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Stigma
Interventions: Pediatric Stigma Education, Pediatric Stigma Standard Education and Adapted Stigma Intervention; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 8 Years and older
Enrollment: 2,980 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Developmental Delays
Interventions: Developmental screening using ASQ and MCHAT; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 30 Months
Enrollment: 2,314 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 4
States / cities: Philadelphia, Pennsylvania

Conditions: Childhood Obesity
Interventions: Playground Stencils; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 3 Years to 6 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Telemedicine, Gait, Hemiplegic, Gait Disorders, Neurologic, Stroke, Orthotic Devices, Gait Analysis
Interventions: Delivery of iStride™ device gait treatment using telemedicine; Device
Lead sponsor: Moterum Technologies, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Search by objective public record fields.

This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer

Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

TEAMS R34 #1 After-Action Reviews in Child Welfare Services

Home-based Conservative Care Model for Advanced Kidney Disease

Turn up the HEAT - Healthy Eating and Activity Time in Summer Day Camps

Incontinence and Quality of Life in Children With Spina Bifida

Guided Self-help for Common Mental Disorders

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention

Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors

Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

Meds@HOME App to Support Medication Safety

Prediction and Prevention of Postoperative Mortality and Morbidity

Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population

Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation

HIV+ Substance Users Released From Jail

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes

Stigma Healing Inventory Evaluation

Translating Evidence Based Developmental Screening Into Pediatric Primary Care

Painted Playgrounds: Aim 2: Assessments

Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™